Beyond Air Inc. (NASDAQ: XAIR) announced that its proposed transaction to sell NeuroNOS subsidiary to XTL Biopharmaceuticals Ltd. has been ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE